Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hypertrophic cardiomyopathies (author's transl)].

H Blömer, W Delius, P Mathes

    MMW, Munchener Medizinische Wochenschrift
    |July 1, 1977
    PubMed
    Summary

    Hypertrophic cardiomyopathies cause unique cardiac issues, including altered left ventricular diastolic compliance and obstructive stenosis. Standard cardiac therapies like digitalis and sympathomimetics are contraindicated in these patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Position paper on the primary prevention of cardiovascular diseases. Current position of the 25.3.2003 Statement of the Board of the German Society of Cardiology--heart and circulatory research work commissioned by for the board by Project Group on Prevention].

    Zeitschrift fur Kardiologie·2005
    Same author

    [The role of lipid metabolism in the prevention of coronary heart disease].

    Zeitschrift fur Kardiologie·2005
    Same author

    [Value of coronary artery calcium measurements in primary prevention].

    Zeitschrift fur Kardiologie·2005
    Same author

    [Cholesterol: blood levels or total risk as a guide to preventive treatment?].

    Zeitschrift fur Kardiologie·2004
    Same author

    [Position paper on primary prevention of cardiovascular diseases. Current edition of 25 March 2003 by the governing body of the German Society of Cardiology-Heart- and Cardiovascular Research, revised by request of the governing body via the Prevention Project Group].

    Zeitschrift fur Kardiologie·2004
    Same author

    Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy.

    European journal of heart failure·2003

    Area of Science:

    • Cardiology
    • Internal Medicine

    Context:

    • Hypertrophic cardiomyopathies (HCM) present complex hemodynamic challenges.
    • These conditions are characterized by altered left ventricular diastolic compliance.
    • Obstructive forms of HCM lead to functional stenosis.

    Purpose:

    • To highlight the unique clinical presentation of hypertrophic cardiomyopathies.
    • To emphasize the contraindication of standard cardiac therapies in HCM.
    • To inform healthcare providers about the special considerations for managing HCM.

    Summary:

    • Hypertrophic cardiomyopathies exhibit rapid hemodynamic changes due to competing physiological processes.
    • Key features include severely impaired left ventricular diastolic compliance.
    • Obstructive HCM involves functional stenosis, complicating diagnosis and treatment.

    Impact:

    • HCM requires specialized management distinct from other cardiac diseases.
    • Physicians must recognize that standard treatments (digitalis, sympathomimetics) are contraindicated.
    • Increased awareness can improve patient outcomes by avoiding inappropriate therapies.

    Related Experiment Videos